Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study

Publikation: Bidrag til tidsskriftKommentar/debat

Standard

Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria : A three months prospective study. / Noshela Ghazanfar, Misbah; Bartko, Ewa Anna; Arildsen, Nicolai Skovbjerg; Poulsen, Lars K; Jensen, Bettina Margrethe; Enevold, Christian; Holm, Jesper Grønlund; Woetmann, Anders; Ødum, Niels; Thomsen, Simon Francis.

I: Clinical and Experimental Allergy, Bind 52, 2022.

Publikation: Bidrag til tidsskriftKommentar/debat

Harvard

Noshela Ghazanfar, M, Bartko, EA, Arildsen, NS, Poulsen, LK, Jensen, BM, Enevold, C, Holm, JG, Woetmann, A, Ødum, N & Thomsen, SF 2022, 'Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study', Clinical and Experimental Allergy, bind 52. https://doi.org/10.1111/cea.14121

APA

Noshela Ghazanfar, M., Bartko, E. A., Arildsen, N. S., Poulsen, L. K., Jensen, B. M., Enevold, C., Holm, J. G., Woetmann, A., Ødum, N., & Thomsen, S. F. (2022). Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study. Clinical and Experimental Allergy, 52. https://doi.org/10.1111/cea.14121

Vancouver

Noshela Ghazanfar M, Bartko EA, Arildsen NS, Poulsen LK, Jensen BM, Enevold C o.a. Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study. Clinical and Experimental Allergy. 2022;52. https://doi.org/10.1111/cea.14121

Author

Noshela Ghazanfar, Misbah ; Bartko, Ewa Anna ; Arildsen, Nicolai Skovbjerg ; Poulsen, Lars K ; Jensen, Bettina Margrethe ; Enevold, Christian ; Holm, Jesper Grønlund ; Woetmann, Anders ; Ødum, Niels ; Thomsen, Simon Francis. / Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria : A three months prospective study. I: Clinical and Experimental Allergy. 2022 ; Bind 52.

Bibtex

@article{29cf65aeac8c4242a9e17045e706ceb0,
title = "Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study",
author = "{Noshela Ghazanfar}, Misbah and Bartko, {Ewa Anna} and Arildsen, {Nicolai Skovbjerg} and Poulsen, {Lars K} and Jensen, {Bettina Margrethe} and Christian Enevold and Holm, {Jesper Gr{\o}nlund} and Anders Woetmann and Niels {\O}dum and Thomsen, {Simon Francis}",
year = "2022",
doi = "10.1111/cea.14121",
language = "English",
volume = "52",
journal = "Clinical Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",

}

RIS

TY - JOUR

T1 - Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria

T2 - A three months prospective study

AU - Noshela Ghazanfar, Misbah

AU - Bartko, Ewa Anna

AU - Arildsen, Nicolai Skovbjerg

AU - Poulsen, Lars K

AU - Jensen, Bettina Margrethe

AU - Enevold, Christian

AU - Holm, Jesper Grønlund

AU - Woetmann, Anders

AU - Ødum, Niels

AU - Thomsen, Simon Francis

PY - 2022

Y1 - 2022

U2 - 10.1111/cea.14121

DO - 10.1111/cea.14121

M3 - Comment/debate

C2 - 35278253

VL - 52

JO - Clinical Allergy

JF - Clinical Allergy

SN - 0954-7894

ER -

ID: 300381204